Medical Devices - New York, New York, United States
OpenCell AI is leveraging the latest advances in computer vision and machine learning to develop commercial software that can screen all clinical microscopy data and automatically assign a preliminary diagnosis amongst a roster of validated diseases, like Acute Promyelocytic Leukemia.Our software can be deployed by hospitals to screen all microscopy samples at a low cost, in order to detect diseases earlier and improve patient outcomes. This screening can, for example, help prioritize the review of samples by a pathologist, thereby allowing for much faster diagnosis and life-saving interventions. This technology can also be deployed for stopgap diagnosis in places where pathologists are inaccessible, such as in rural areas or developing countries.